Name: Recombinant Human Retinitis Pigmentosa 9
Price: Inquiry

- Overview
  - RP9 Human Recombinant produced in E. Coli is a single, non-glycosylated polypeptide chain containing 178 amino acids (1-155 a.a.) and having a molecular mass of 20.7kDa. RP9 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. Retinitis pigmentosa 9 (RP9) is assumed to be a target protein for the PIM1 kinase. The RP9 protein may have some roles in B-cell proliferation in association with PIM1. RP9 can be bound and phosphorylated by the protooncogene PIM1 product, a serine/threonine protein kinase. RP9 localizes in nuclear speckles containing the splicing factors, and has a part in pre-mRNA splicing. RP9 gene mutations result in autosomal dominant retinitis pigmentosa-9.
    
    Please contact us at for specific academic pricing.
- Properties
  - Protein Name
    
    Retinitis pigmentosa 9 protein, Pim-1-associated protein, PAP-1, RP9.
    
    Source
    
    E. coli
    
    Type
    
    Recombinant Proteins
    
    Purification
    
    Greater than 85.0% as determined by SDS-PAGE.
    
    Formulation
    
    RP9 protein solution (0.5mg/ml) containing 20mM Tris-HCl buffer (pH 8.0), 0.2M NaCl, 20% glycerol and 1mM DTT.
    
    Storage
    
    Store at 4°C if entire vial will be used within 2-4 weeks. Store, frozen at -20°C for longer periods of time. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid multiple freeze-thaw cycles.
    
    * For Research Use Only. Not for use in diagnostic/therapeutics procedures.

Recombinant Human Retinitis Pigmentosa 9

Recombinant Human Retinitis Pigmentosa 9

We Also Recommend

Recombinant Human Replication Protein A2

Recombinant Human Ribosomal Protein L26-Like 1

Recombinant Human RPA Interacting Protein